Skip to main content

Beneficial ownership — 13D / 13G

87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Irrevocable Larson Family Investment Trust RMTI Rockwell Medical, Inc. 13G/A 9.1% 2y
BIOS EQUITY PARTNERS, LP AZTR Azitra, Inc. 13D/A 0.07% 2y
Saba Capital Management, L.P. AOD abrdn Total Dynamic Dividend Fund 13D 5.39% 2y
Cortice Biosciences, Inc. CNSP CNS Pharmaceuticals, Inc. 13D 5.7% 2y
Cuizhang Gong GDHG Golden Heaven Group Holdings Ltd. 13D/A 71.6% 2y
David A. Eklund PRPO Precipio, Inc. 13G 5.73% 2y
Invus Public Equities, L.P. IGMS IGM Biosciences, Inc. Common Stock 13G/A 9.9% 2y
Invus Public Equities, L.P. GOSS Gossamer Bio, Inc. 13G/A 6.3% 2y
Invus Public Equities, L.P. SEER Seer, Inc. 13G/A 6.9% 2y
GLAZER CAPITAL, LLC HOLI Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island) 13G 0% 2y
Invus Public Equities, L.P. SLDB Solid Biosciences Inc. 13G/A 6.5% 2y
Invus Public Equities, L.P. HOOK HOOKIPA Pharma Inc. 13G/A 5.9% 2y
Invus Public Equities, L.P. SLN Silence Therapeutics plc 13G/A 6% 2y
NEEDHAM INVESTMENT MANAGEMENT LLC NTIC Northern Technologies International Corp 13G 5.3% 2y
Mitchell P. Kopin NUWE Nuwellis, Inc. 13G 4.99% 2y
Blackstone Holdings II L.P. CMPX Compass Therapeutics, Inc. 13G 6.9% 2y
Encompass Capital Advisors LLC SEI Solaris Energy Infrastructure, Inc. 13G 5.2% 2y
SZOP Opportunities I LLC QOMO Qomolangma Acquisition Corp. Common Stock 13G 5.1% 2y
Wilson Garrett Patrick UAVS AgEagle Aerial Systems Inc. 13G/A — 2y
SAMLYN CAPITAL, LLC CRVS Corvus Pharmaceuticals, Inc. 13G/A 9.99% 2y
Galkin Vladimir JBLU Jetblue Airways Corp 13G/A 7% 2y
Board of Directors of MetLife, Inc., as an entity MET Metlife Inc 13D/A 16.3% 2y
IndexIQ Advisors LLC UUP Invesco DB US Dollar Index Bullish Fund 13G/A 17.8% 2y
Genesis Park II LP RDW Redwire Corp 13G 12.1% 2y
Ernest C. Garcia II CVNA Carvana Co. 13D/A 38.9% 2y
ECP ControlCo, LLC SHEN Shenandoah Telecommunications Co 13D/A 10% 2y
GOLDMAN SACHS GROUP INC MIR Mirion Technologies, Inc. 13D/A 8.3% 2y
WARBURG PINCUS LLC BANC Banc Of California, Inc. 13D/A 9.88% 2y
Phoenix Financial Ltd. CTV Innovid Corp. 13G 5.13% 2y
Saba Capital Management, L.P. GDV Gabelli Dividend & Income Trust 13D 5.06% 2y
G-Star Management Corporation GODN Golden Star Acquisition Corporation Ordinary Shares 13D/A 44.82% 2y
CVI Investments, Inc. AZTR Azitra, Inc. 13G 8% 2y
ADAR1 Capital Management, LLC PVLA Palvella Therapeutics, Inc. 13G 10.5% 2y
DISCOVERY CAPITAL MANAGEMENT, LLC / CT AMC Amc Entertainment Holdings, Inc. 13G 6.3% 2y
venBio Global Strategic Fund III, L.P. ARTV Artiva Biotherapeutics, Inc. 13G 7.8% 2y
5AM Ventures VI, L.P. ARTV Artiva Biotherapeutics, Inc. 13G 10.1% 2y
Mudrick Capital Management, L.P. AMC Amc Entertainment Holdings, Inc. 13G 4.6% 2y
Venrock Healthcare Capital Partners III, L.P. ARTV Artiva Biotherapeutics, Inc. 13G 6.9% 2y
Chain of Lakes Investment Fund, LLC LTRX Lantronix Inc 13D/A 3.2% 2y
Cascade Investment, L.L.C. AN Autonation, Inc. 13D/A 24.9% 2y
Riot Platforms, Inc. KEEL Keel Infrastructure Corp. 13D/A 15.9% 2y
HGC NEXT INV LLC NEXT NextDecade Corp 13D/A 9.1% 2y
Matthew T. Moroun PAMT Pamt Corp 13D/A 73.6% 2y
Radoff Bradley Louis LFVN Lifevantage Corp 13D/A 4.99% 2y
L1 Capital Global Opportunities Master Fund, Ltd. CTNT Cheetah Net Supply Chain Service Inc. 13G 8.08% 2y
Zekelman Industries, Inc. ASTL Algoma Steel Group Inc. 13D 5.02% 2y
Yelin Lapidot Holdings Management Ltd. ENLT Enlight Renewable Energy Ltd. 13G 5.08% 2y
BlackRock Inc. VTNR Vertex Energy, Inc 13D 5.4% 2y
WOLVERINE ASSET MANAGEMENT LLC AFAR Aura FAT Projects Acquisition Corp Class A Ordinary Shares 13G/A 0% 2y
Prime Link Capital International Limited SFWL SHENGFENG DEVELOPMENT Ltd 13G 4.4% 2y